Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Exploring Psilocybin Treatments in Underserved Indications Jul 30, 2021
Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor Jul 26, 2021
Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan Jul 21, 2021
Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations Jul 7, 2021
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Charting Its Own Course in Psychedelic Space Jun 30, 2021
Strong Psychedelic Data In 1H 2021 Sets The Stage For Key Endpoint Results Later This Year Jun 23, 2021